About this trial
The tobacco use burden in Lebanon is exceptionally high: 35% of adults are current cigarette smokers and 39% are current waterpipe smokers. Although the World Health Organization endorses evidence-based interventions for population-level tobacco dependence treatment, recommended treatments are not integrated as a routine part of primary care in Lebanon, as is the case in other low-resource settings. The objective of this proposal is to evaluate the comparative effectiveness of promising multi-component interventions for implementing evidence-based cessation treatment in Lebanon's national system of primary health care centers.
Eligibility criteria
Qualifiers
Age 18+
A current daily cigarette smoker and/or a regular waterpipe smoker (smokes at least 1-2 times/week).
Not pregnant
Reachable by phone
Disqualifiers
Patients who use other tobacco products including vape exclusively.
Any patient below 18 years old.
Cigarette smokers who do not smoke on daily basis.
Waterpipe smokers who smoke less than once/weekly
Trial design
Treatments tested in this trial
- Educational materials
- Phone counseling
- Nicotine Replacement Therapy
- Provider training
- Electronic reminders
Treatment groups
Sponsors and collaborators
University of Florida
Lead sponsor
National Cancer Institute (NCI)
Collaborator